We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+7.58%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$2.41B
AUM Growth
-$3.75B
Cap. Flow
-$4.09B
Cap. Flow %
-169.35%
Top 10 Hldgs %
31.78%
Holding
6,989
New
537
Increased
1,703
Reduced
3,620
Closed
686

Sector Composition

Rank Sector Weight
1 Technology 21.71%
2 Healthcare 7.7%
3 Consumer Discretionary 6.83%
4 Financials 6.52%
5 Industrials 4.92%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AVDL
2426
DELISTED
Avadel Pharmaceuticals
AVDL
$45K ﹤0.01%
6,250
-8,114
-56% -$56.9K
BELFB
2427
Bel Fuse Inc Class B
BELFB
$4.13B
$45K ﹤0.01%
1,380
+985
+249% +$32.2K
BPMC
2428
DELISTED
Blueprint Medicines
BPMC
$45K ﹤0.01%
1,019
-10,174
-91% -$488K
CABA icon
2429
Cabaletta Bio
CABA
$442M
$45K ﹤0.01%
4,910
-12,628
-72% -$46K
CGNT icon
2430
Cognyte Software
CGNT
$692M
$45K ﹤0.01%
14,306
+12,726
+805% +$37.4K
LADR
2431
Ladder Capital
LADR
$1.27B
$45K ﹤0.01%
4,471
-10,111
-69% -$105K
LTRX icon
2432
Lantronix
LTRX
$272M
$45K ﹤0.01%
10,416
+7,947
+322% +$37.4K
MIRM icon
2433
Mirum Pharmaceuticals
MIRM
$6.02B
$45K ﹤0.01%
2,329
+119
+5% +$2.35K
FLNA
2434
Filana Therapeutics
FLNA
$45.7M
$45K ﹤0.01%
1,541
+187
+14% +$6.72K
UMC icon
2435
United Microelectronic
UMC
$48.6B
$45K ﹤0.01%
6,936
-29,019
-81% -$192K
USIG icon
2436
iShares Broad USD Investment Grade Corporate Bond ETF
USIG
$17.4B
$45K ﹤0.01%
911
+511
+128% +$24.9K
VCYT icon
2437
Veracyte
VCYT
$3.42B
$45K ﹤0.01%
1,897
-42,391
-96% -$985K
WHD icon
2438
Cactus
WHD
$5.78B
$45K ﹤0.01%
896
-6,213
-87% -$312K
PYCR
2439
DELISTED
Paycor HCM, Inc. Common Stock
PYCR
$45K ﹤0.01%
1,836
+1,635
+813% +$45.3K
BNIX
2440
DELISTED
Bannix Acquisition Corp. Common Stock
BNIX
$45K ﹤0.01%
4,379
RBCP
2441
DELISTED
RBC Bearings Incorporated 5.00% Series A Mandatory Convertible Preferred Stock
RBCP
$45K ﹤0.01%
441
TGH
2442
DELISTED
Textainer Group Holdings limited
TGH
$45K ﹤0.01%
1,462
-3,291
-69% -$97.6K
ALLY icon
2443
Ally Financial
ALLY
$13.6B
$44K ﹤0.01%
1,804
-12,140
-87% -$323K
APLS
2444
DELISTED
Apellis Pharmaceuticals
APLS
$44K ﹤0.01%
859
-7,686
-90% -$408K
CAL icon
2445
Caleres
CAL
$461M
$44K ﹤0.01%
1,996
-5,652
-74% -$139K
DBO icon
2446
Invesco DB Oil Fund
DBO
$387M
$44K ﹤0.01%
2,890
-3,204
-53% -$51K
DNLI icon
2447
Denali Therapeutics
DNLI
$3.97B
$44K ﹤0.01%
1,554
-12,662
-89% -$377K
OBK icon
2448
Origin Bancorp
OBK
$1.69B
$44K ﹤0.01%
1,197
-3,183
-73% -$126K
OCFT
2449
DELISTED
OneConnect Financial Technology
OCFT
$44K ﹤0.01%
+8,187
New +$56.2K
SA
2450
Seabridge Gold
SA
$3.46B
$44K ﹤0.01%
3,550
+216
+6% +$2.56K

Similar funds

Tower Research Capital (TRC)'s Q4 2022 Portfolio in Review

As of Q4 2022, Tower Research Capital (TRC) held 6,989 positions worth $2.41B, down 61% from $6.16B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Tower Research Capital (TRC) withdrew a net $4.09B in Q4 2022, closing 686 positions and reducing 3,620 holdings. Its most notable exit was Vanguard Russell 2000 Value ETF, an estimated $4.46M position sold in full.

By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 27% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Tower Research Capital (TRC) opened a new position in iShares Semiconductor ETF worth $9.33M.

  • Tower Research Capital (TRC)'s largest Q4 2022 buy was iShares Semiconductor ETF: 80,454 shares worth $9.33M.
  • Tower Research Capital (TRC) added most to iShares Russell 2000 ETF in Q4 2022, an estimated $145M increase.
  • Tower Research Capital (TRC)'s biggest Q4 2022 reduction was Apple, cutting an estimated $322M.
  • Tower Research Capital (TRC) fully exited Vanguard Russell 2000 Value ETF in Q4 2022, selling an estimated $4.46M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 32% of its $2.41B portfolio in Q4 2022.
  • Tower Research Capital (TRC) opened 537 new positions and closed 686 in Q4 2022.
  • Tower Research Capital (TRC)'s portfolio value fell 61% quarter-over-quarter to $2.41B.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2022, filed 10 Feb 2023.